116 related articles for article (PubMed ID: 16156689)
1. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
Thadani U
Am J Cardiovasc Drugs; 2005; 5(5):331-4. PubMed ID: 16156689
[No Abstract] [Full Text] [Related]
2. Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice.
Gupta R; Sawhney JP; Narain VS
Am J Cardiovasc Drugs; 2005; 5(5):325-9. PubMed ID: 16156688
[TBL] [Abstract][Full Text] [Related]
3. [Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study].
Vasiuk YA; Shkol'nik EL; Kudriakov ON; Kulikov KG
Kardiologiia; 2010; 50(4):45-9. PubMed ID: 20459421
[No Abstract] [Full Text] [Related]
4. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
McClellan KJ; Plosker GL
Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
[TBL] [Abstract][Full Text] [Related]
5. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
[TBL] [Abstract][Full Text] [Related]
7. Single Ascending Dose Study to Assess Pharmacokinetic Linearity, Safety, and Tolerability of Trimetazidine - Modified Release in Healthy Human Subjects.
Körnicke T; Arora D; Samad A; Kaplan S; Domahidy M; de Voogd H; Böhmert S; Ramos RS; Jain S
Drug Res (Stuttg); 2020 Oct; 70(10):472-477. PubMed ID: 32886932
[TBL] [Abstract][Full Text] [Related]
8. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
Meiszterics Z; Kónyi A; Hild G; Sárszegi Z; Gaszner B
J Comp Eff Res; 2017 Nov; 6(8):649-657. PubMed ID: 29148291
[TBL] [Abstract][Full Text] [Related]
11. Food effect on bioavailability of modified-release trimetazidine tablets.
Ozbay L; Unal DO; Erol D
J Clin Pharmacol; 2012 Oct; 52(10):1535-9. PubMed ID: 22162540
[TBL] [Abstract][Full Text] [Related]
12. Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study.
Rogacka D; Guzik P; Wykretowicz A; Rzeźniczak J; Dziarmaga M; Wysocki H
Coron Artery Dis; 2000 Mar; 11(2):171-7. PubMed ID: 10758819
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
[TBL] [Abstract][Full Text] [Related]
14. [Adherence of patients with stable angina to treatment with trimetazidine MR and frequency of emergency medical care: results of the EFFECT study].
Glezer MG; Saĭgitov RT
Kardiologiia; 2012; 52(11):4-11. PubMed ID: 23237390
[TBL] [Abstract][Full Text] [Related]
15. [Program for detection of patients with ineffective therapy with beta-adrenoblockers and comparative assessment of efficacy of addition of trimetazidine MB or isosorbide dinitrate in stable angina. Results of a Russian Study Parrallel].
Oganov RG; Glezer MG; Deev AD
Kardiologiia; 2007; 47(3):4-13. PubMed ID: 17506199
[No Abstract] [Full Text] [Related]
16. [The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases].
Vasiuk IuA; Shal'nova SA; Shkol'nik EL; Kulikov KG
Kardiologiia; 2008; 48(12):10-3. PubMed ID: 19076088
[No Abstract] [Full Text] [Related]
17. [Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Zhiliaev EV; Urzhumova TV; Glazunov AV; Sorokoletov SM; Dzhanashiia PKh
Ter Arkh; 2000; 72(8):20-3. PubMed ID: 11019420
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the sustained release properties of a new oral formulation of trimetazidine in pigs and dogs and confirmation in healthy human volunteers.
Génissel P; Chodjania Y; Demolis JL; Ragueneau I; Jaillon P
Eur J Drug Metab Pharmacokinet; 2004; 29(1):61-8. PubMed ID: 15151172
[TBL] [Abstract][Full Text] [Related]
19. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
Chaloupka V
Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765
[TBL] [Abstract][Full Text] [Related]
20. [The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Vasiuk IuA; Shal'nova SA; Shkol'nik EL; Kulikov KG
Kardiologiia; 2011; 51(6):11-5. PubMed ID: 21878064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
